Evidence map›Paper›PMID 25959156›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2015

Persistent rhinovirus infection in pediatric hematopoietic stem cell transplant recipients with impaired cellular immunity.

Antonio Piralla, Marco Zecca, Patrizia Comoli, Alessia Girello, Rita Maccario, Fausto Baldanti

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. The rhinovirus puzzle: Linking virus and host factors to childhood asthma.The Journal of allergy and clinical immunology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Antonio PirallaMolecular Virology Unit, Microbiology and Virology Department, Pavia, Italy.
Marco ZeccaPediatric Hematology-Oncology and Research Laboratories, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Patrizia ComoliPediatric Hematology-Oncology and Research Laboratories, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessia GirelloMolecular Virology Unit, Microbiology and Virology Department, Pavia, Italy.
Rita MaccarioPediatric Hematology-Oncology and Research Laboratories, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Fausto BaldantiMolecular Virology Unit, Microbiology and Virology Department, Pavia, Italy; Section of Microbiology, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy. Electronic address: f.baldanti@smatteo.pv.it.
University of Pavia · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHRV infections are generally self-limiting in healthy subjects, whereas in immunocompromised hosts HRV infections can lead to severe complications and persistent infections. The persistence of HRV shedding could be due to the inefficient immunological control of a single infectious episode.

objectivesTo investigate the clinical, virologic and immunologic characteristics of pediatric HSCT recipients with HRV-PI infection. STUDY

designDuring the period 2006-2012, eight hematopoietic stem cell transplant (HSCT) recipients presented with persistent rhinovirus infection (HRV-PI, ≥30 days). Viral load and T-CD4(+), T-CD8(+), B and NK lymphocyte counts at the onset of infection were compared with those of fourteen HSCT recipients with acute HRV infection (HRV-AI, ≤15 days).

resultsThe median duration of HRV positivity in patients with HRV-PI was 61 days (range 30-174 days) and phylogenetic analysis showed the persistence of a single HRV type in all patients (100%). In HSCT recipients with HRV-PI, T-CD4(+), T-CD8(+) and NK cell counts at the onset of infection were significantly lower than those observed in recipients with HRV-AI (p<0.01), while B cell counts were similar in the two groups (p= 0.25). A decrease in HRV load was associated with a significant increase in T-CD4(+), T-CD8(+)and NK lymphocyte counts in HRV-PI patients (p<0.01).

conclusionsThis study suggests a role for cellular immunity in HRV clearance and highlights the importance of its recovery for the control of HRV infection in HSCT recipients.

Indexed as

Hematopoietic Stem Cell TransplantationImmunity, CellularTransplant RecipientsAdolescentB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChildChild, PreschoolFemaleHumansImmunocompromised HostInfantKiller Cells, NaturalLymphocyte CountMaleCellular immunityHematopoietic stem cell transplant recipientsHRV persistent infectionImmunocompromised pediatric patients

Identifiers

PMID25959156
PMCPMC7172262
OpenAlexW2055100779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.